ArticleNew biotechnology2021
Towards a bioeconomic vision for New Zealand - Unlocking barriers to enable new pathways and trajectories.
Article in New biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There has been significant national interest and movement towards bioeconomic policy over the past decade. Through an examination of the current bioeconomic pathways in New Zealand, this paper outlines key barriers that transition pathways will need to overcome and factors needing development within the country's bioeconomic environment. New Zealand's strength in primary production, coupled with a market-led economy and recent green growth with low carbon policies, provide an excellent platform for bioeconomic development. However, the strength in established biological industries and lack of clearly defined vision or cohesive support for bioeconomic development provide sufficient inertia to realising the full potential. For a bioeconomy in New Zealand to flourish, a primary sector model that is cohesive and more integrated is needed to develop new niche industries and attract finance, while providing an overarching governance system to the primary industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.